The Coalition and Med Ad News are collaborating on a series of podcasts by John Kamp, Coalition Executive Director, on topics vital to the healthcare communication industry. The 4th podcast, “Approach with Caution,” is now available for download. In this segment, Mr. Kamp talks about social media, why legal departments will continue to voice strong resistance to going too far and he also acknowledges the great opportunity social media hold in improving the industry relationship and reputation with consumers.
All 4 podcasts can be downloaded here: http://downloads.pharmalive.com/
From Tom Sullivan’s Policy and Medicine blog:
Tom Sullivan cites a recent article on industry support of CME in Clinical Pharmacology & Therapeutics and elaborates on its argument that “…some of healthcare’s greatest contributions have originated from industry-sponsored science,” and says that to eliminate the industry now would be detrimental to patients.
Read more on their website
We encourage and welcome your comments.
From Washington Legal Foundation:
On June 21, 2007, U.S. Representative Pete Stark introduced a bill titled the “Fair Balance Prescription Drug Advertisement Act of 2007.” H.R. 2823 (110th Cong., 1st Sess.). If enacted, the bill would deny a tax deduction for any expenses associated with a direct-to-consumer (“DTC”) advertisement for a new prescription drug for the first 2 years after approval.
Read more on their website
Recent Comments